Company Filing History:
Years Active: 1999-2008
Title: Innovations in Medical Diagnostics: The Contributions of S Mark O'Hara
Introduction
S Mark O'Hara, based in Oklahoma City, OK, has made significant strides in the field of medical diagnostics through his inventive work. With a portfolio of four patents, O'Hara's contributions primarily focus on the detection and evaluation of human disease states, particularly through innovative use of genetic and protein biomarkers.
Latest Patents
O'Hara's recent patents encompass groundbreaking diagnostic techniques. One of his notable inventions, titled "Diagnosis of disease state using mRNA profiles in peripheral leukocytes," introduces methods for detecting disease states affecting gene expression. This invention specifically details probes and methods for identifying RNA species that are differentially expressed in individuals suffering from conditions such as prostate and breast cancer. Additionally, it includes the detection of related protein species, aiding in both diagnosis and monitoring.
Another significant patent by O'Hara is centered on "Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer." This invention enhances diagnostic techniques for detecting prostate, bladder, and breast cancers by utilizing genetic probes to monitor the disease progression. Through these innovative methods, O'Hara's work provides essential tools for distinguishing cancerous tissues from normal counterparts, enabling better management and diagnostic accuracy.
Career Highlights
S Mark O'Hara's professional journey is marked by a strong commitment to advancing medical science. He is currently associated with Urocor, Inc., where he leverages his expertise in medical diagnostics to drive innovations in cancer detection. His work has garnered attention for its potential to significantly improve patient outcomes through earlier and more accurate diagnoses.
Collaborations
Throughout his career, O'Hara has collaborated with notable colleagues such as Gang An and David Ralph. Together, they contribute to a collaborative environment that fosters innovative research and development, ultimately enhancing the efficacy of cancer diagnostics.
Conclusion
S Mark O'Hara exemplifies the spirit of innovation in the medical field by focusing on the early detection of critical illnesses. His patents not only mark significant advancements in diagnostics but also reflect his dedication to improving health outcomes for individuals affected by cancer. As he continues his work at Urocor, Inc., the impact of his inventions will undoubtedly resonate within the medical community and beyond.